These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 15599880

  • 21. ANCA-mediated crescentic glomerulonephritis with linear deposition of IgG along the glomerular basement membrane.
    Sangsiraprapha W, Truong L, Mandayam S.
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):634-7. PubMed ID: 24821165
    [Abstract] [Full Text] [Related]

  • 22. [Microscopic polyarteritis].
    Lauque D, Estivals M, Tubery M, Pourrat J, Carles P.
    Rev Pneumol Clin; 1993 May; 49(6):277-82. PubMed ID: 7915043
    [Abstract] [Full Text] [Related]

  • 23. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies.
    Yang R, Hellmark T, Zhao J, Cui Z, Segelmark M, Zhao MH, Wang HY.
    J Am Soc Nephrol; 2007 Apr; 18(4):1338-43. PubMed ID: 17329569
    [Abstract] [Full Text] [Related]

  • 24. Anti-neutrophil cytoplasm-associated glomerulonephritis.
    Morgan MD, Harper L, Williams J, Savage C.
    J Am Soc Nephrol; 2006 May; 17(5):1224-34. PubMed ID: 16624931
    [Abstract] [Full Text] [Related]

  • 25. Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis.
    Lionaki S, Jennette JC, Falk RJ.
    Semin Immunopathol; 2007 Nov; 29(4):459-74. PubMed ID: 17943286
    [Abstract] [Full Text] [Related]

  • 26. [Rapidly progressive glomerulonephritis (RPGN): Pathogenesis, pathophysiology, and therapy].
    Shimizu Y, Yamagata K, Koyama A.
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():403-7. PubMed ID: 16523922
    [No Abstract] [Full Text] [Related]

  • 27. Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis.
    de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N, Noël LH, Ferrario F, Waldherr R, Bruijn JA, Bajema IM, Hagen EC, Pusey CD, EUVAS.
    J Am Soc Nephrol; 2007 Jul; 18(7):2189-97. PubMed ID: 17596637
    [Abstract] [Full Text] [Related]

  • 28. Pulmonary-renal syndrome: a life threatening but treatable condition.
    West SC, Arulkumaran N, Ind PW, Pusey CD.
    Postgrad Med J; 2013 May; 89(1051):274-83. PubMed ID: 23349383
    [Abstract] [Full Text] [Related]

  • 29. [Rapidly progressive glomerulonephritis in a solitary kidney positive for anti-glomerular basement membrane antibodies and antineutrophil cytoplasmic antibodies].
    Rychlík I, Tesar V, Zabka J, Zima T, Stejskalová A, Lachmanová J.
    Cas Lek Cesk; 1994 May 16; 133(10):311-4. PubMed ID: 8004656
    [Abstract] [Full Text] [Related]

  • 30. [Crescentic glomerulonephritis].
    Esnault VL, Moreau A, Testa A, Besnier D.
    Nephrol Ther; 2006 Dec 16; 2(7):446-60. PubMed ID: 17185236
    [Abstract] [Full Text] [Related]

  • 31. Chronic bronchiectasis and anti-myeloperoxidase antibody related rapidly progressive necrotizing glomerulonephritis.
    Pai P, Rustom R, Bone JM, Bell GM.
    Clin Nephrol; 1998 Apr 16; 49(4):262-4. PubMed ID: 9582559
    [Abstract] [Full Text] [Related]

  • 32. Anti-glomerular basement membrane vasculitis.
    Ponticelli C, Calatroni M, Moroni G.
    Autoimmun Rev; 2023 Jan 16; 22(1):103212. PubMed ID: 36252931
    [Abstract] [Full Text] [Related]

  • 33. Pulmonary renal vasculitis syndromes.
    Lee RW, D'Cruz DP.
    Autoimmun Rev; 2010 Aug 16; 9(10):657-60. PubMed ID: 20472100
    [Abstract] [Full Text] [Related]

  • 34. [Anti-GBM glomerulonephritis and RPGN].
    Shimizu Y, Tomino Y.
    Nihon Jinzo Gakkai Shi; 2009 Aug 16; 51(2):94-7. PubMed ID: 19378793
    [No Abstract] [Full Text] [Related]

  • 35. IgA deposits along glomerular basement membranes in rapidly progressive glomerulonephritis.
    Cai G, Chen P, Wu D, Shi S, Yin Z, Zhang X, Wei R, Chen X.
    South Med J; 2008 Sep 16; 101(9):945-7. PubMed ID: 18708970
    [Abstract] [Full Text] [Related]

  • 36. The Effects of Plasma Exchange on Severe Vasculitis with Diffuse Alveolar Hemorrhage.
    Goto K, Nakai K, Fujii H, Nishi S.
    Intern Med; 2017 Sep 16; 56(1):55-59. PubMed ID: 28050000
    [Abstract] [Full Text] [Related]

  • 37. [Rapidly progressive glomerulonephritis in ANCA-associated vasculitis: a course, treatment efficacy, prognosis].
    Tomilina NA, Biriukova LS, Egorova ET, Sukhanov AV, Stoliarevich ES, Kupavtseva OA, Fedorova ND, Frolov AV, Trushkin RN, Kurenkova LG.
    Ter Arkh; 2008 Sep 16; 80(6):15-24. PubMed ID: 18655470
    [Abstract] [Full Text] [Related]

  • 38. Membranous glomerulonephritis associated with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Zhou GY.
    Nefrologia; 2012 Jul 17; 32(4):548-51. PubMed ID: 22806300
    [No Abstract] [Full Text] [Related]

  • 39. Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center.
    Li ZY, Gou SJ, Chen M, Zhao MH.
    Semin Arthritis Rheum; 2013 Apr 17; 42(5):515-21. PubMed ID: 23332902
    [Abstract] [Full Text] [Related]

  • 40. Plasmapheresis with immunosuppressive therapy vs immunosuppressive therapy alone for rapidly progressive anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.
    Nakamura T, Matsuda T, Kawagoe Y, Ueda Y, Ebihara I, Koide H.
    Nephrol Dial Transplant; 2004 Jul 17; 19(7):1935-7. PubMed ID: 15199209
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.